Innophos Holdings, Inc. (IPHS) Shares Bought by Penn Capital Management Co. Inc.

Penn Capital Management Co. Inc. increased its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 16.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 136,180 shares of the specialty chemicals company’s stock after purchasing an additional 19,653 shares during the quarter. Penn Capital Management Co. Inc. owned approximately 0.69% of Innophos worth $4,104,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in IPHS. Bank of Montreal Can lifted its stake in shares of Innophos by 79.8% in the 4th quarter. Bank of Montreal Can now owns 1,300 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 577 shares during the period. Versant Capital Management Inc lifted its stake in shares of Innophos by 75.0% in the 1st quarter. Versant Capital Management Inc now owns 1,612 shares of the specialty chemicals company’s stock valued at $48,000 after purchasing an additional 691 shares during the period. Public Employees Retirement System of Ohio lifted its stake in shares of Innophos by 14.1% in the 4th quarter. Public Employees Retirement System of Ohio now owns 2,708 shares of the specialty chemicals company’s stock valued at $66,000 after purchasing an additional 334 shares during the period. Quantamental Technologies LLC purchased a new position in shares of Innophos in the 4th quarter valued at approximately $81,000. Finally, Metropolitan Life Insurance Co. NY lifted its stake in shares of Innophos by 353.5% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 6,403 shares of the specialty chemicals company’s stock valued at $157,000 after purchasing an additional 4,991 shares during the period. Institutional investors own 91.18% of the company’s stock.

A number of research analysts have recently commented on IPHS shares. TheStreet upgraded Innophos from a “c” rating to a “b-” rating in a research note on Thursday, February 21st. Zacks Investment Research raised Innophos from a “sell” rating to a “hold” rating in a research report on Tuesday, April 30th. BidaskClub lowered Innophos from a “buy” rating to a “hold” rating in a research report on Friday, March 1st. ValuEngine raised Innophos from a “strong sell” rating to a “sell” rating in a research report on Monday, February 4th. Finally, Seaport Global Securities began coverage on Innophos in a research report on Thursday, February 21st. They set a “buy” rating for the company. One research analyst has rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company. The company currently has an average rating of “Hold”.

IPHS stock opened at $30.23 on Thursday. Innophos Holdings, Inc. has a twelve month low of $22.57 and a twelve month high of $50.40. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.14 and a quick ratio of 1.49. The company has a market cap of $596.20 million, a P/E ratio of 13.26 and a beta of 1.33.

Innophos (NASDAQ:IPHS) last posted its quarterly earnings data on Tuesday, April 30th. The specialty chemicals company reported $0.57 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.14. Innophos had a return on equity of 13.09% and a net margin of 4.30%. The company had revenue of $191.41 million during the quarter, compared to analyst estimates of $199.90 million. During the same quarter last year, the company earned $0.61 EPS. The firm’s revenue for the quarter was down 6.8% on a year-over-year basis. Equities research analysts forecast that Innophos Holdings, Inc. will post 2.36 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 7th. Investors of record on Friday, May 17th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 6.35%. The ex-dividend date of this dividend is Thursday, May 16th. Innophos’s dividend payout ratio (DPR) is presently 84.21%.

COPYRIGHT VIOLATION NOTICE: “Innophos Holdings, Inc. (IPHS) Shares Bought by Penn Capital Management Co. Inc.” was reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2019/05/16/innophos-holdings-inc-iphs-shares-bought-by-penn-capital-management-co-inc.html.

About Innophos

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Featured Article: Are sell-side analysts objective?

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply